Cargando…

Patterns of antiplatelet drug use after a first myocardial infarction during a 10‐year period

AIMS: The aims of the present study were to assess antiplatelet drug use patterns after a first myocardial infarction (MI) and to evaluate the determinants of antiplatelet nonpersistence. METHODS: The present study was conducted in 4690 patients from the Utrecht Cardiovascular Pharmacogenetics cohor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yasmina, Alfi, de Boer, Anthonius, Deneer, Vera H.M., Souverein, Patrick C., Klungel, Olaf H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Pharmacoepidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306486/ https://www.ncbi.nlm.nih.gov/pubmed/27662521 http://dx.doi.org/10.1111/bcp.13139

Ejemplares similares

Risk of myocardial infarction associated with non‐steroidal anti‐inflammatory drugs: Impact of additional confounding control for variables collected from self‐reported data
por: Bakhriansyah, Mohammad, et al.
Publicado: (2019)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
por: van de Garde, Ewoudt MW, et al.
Publicado: (2007)

Use of antidepressants and the risk of myocardial infarction in middle-aged and older adults: a matched case-control study
por: Noordam, Raymond, et al.
Publicado: (2015)

Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study
por: García Rodríguez, Luis A., et al.
Publicado: (2021)

Trends and variations in the prescribing of secondary preventative cardiovascular therapies for non-ST elevation myocardial infarction (NSTEMI) in Malaysia
por: Venkatason, Padmaa, et al.
Publicado: (2018)

Validation of suicide and self-harm records in the Clinical Practice Research Datalink
por: Thomas, Kyla H, et al.
Publicado: (2013)

EUROmediCAT signal detection: an evaluation of selected congenital anomaly‐medication associations
por: Given, Joanne E., et al.
Publicado: (2016)

Gastrointestinal toxicity among patients taking selective COX‐2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case–control study
por: Bakhriansyah, Mohammad, et al.
Publicado: (2017)

The role of Periodic Safety Update Reports in the safety management of biopharmaceuticals
por: Ebbers, Hans C., et al.
Publicado: (2012)

‘Real-life’ reduction in cholesterol with statins, 1993 to 2002
por: Murphy, Michael J, et al.
Publicado: (2008)

Impact of allopurinol use on urate concentration and cardiovascular outcome
por: Wei, Li, et al.
Publicado: (2011)

Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes
por: Mackenzie, Isla S, et al.
Publicado: (2012)

Prevalence, nature and potential preventability of adverse drug events – a population-based medical record study of 4970 adults
por: Hakkarainen, Katja M, et al.
Publicado: (2014)

The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort
por: Douglas, Ian J, et al.
Publicado: (2015)

A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC
por: Blin, Patrick, et al.
Publicado: (2015)

Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink
por: Goh, Kah L, et al.
Publicado: (2015)

A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors
por: Cressman, Alex M, et al.
Publicado: (2015)

Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug‐induced liver injury case–control study in Italy
por: Donati, Monia, et al.
Publicado: (2016)

Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self‐controlled study designs
por: Root, Adrian A., et al.
Publicado: (2016)

Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study
por: Chan, Sze Ling, et al.
Publicado: (2016)

Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study
por: Glamočlija, Una, et al.
Publicado: (2018)

Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations
por: Alping, Peter, et al.
Publicado: (2019)

Spironolactone use and risk of incident cancers: a retrospective, matched cohort study
por: Mackenzie, Isla S., et al.
Publicado: (2016)

Evaluation of Medication-mediated Effects in Pharmacoepidemiology
por: Tchetgen Tchetgen, Eric J., et al.
Publicado: (2017)

Evaluating beneficial drug effects in a non‐interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register data
por: Wallerstedt, Susanna M., et al.
Publicado: (2017)

A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU
por: Weatherall, Mary, et al.
Publicado: (2017)

Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research
por: Pang, Menglan, et al.
Publicado: (2016)

Comparison of Antihypertensive Drug Classes for Dementia Prevention
por: Walker, Venexia M., et al.
Publicado: (2020)

Prenatal Opioid Analgesics and the Risk of Adverse Birth Outcomes
por: Brogly, Susan B., et al.
Publicado: (2021)

A historical cohort study to investigation of statins safety in COVID-19 hospitalized patients
por: Nateghi, Saeed, et al.
Publicado: (2022)

Causal Effect of Chronic Pain on Mortality Through Opioid Prescriptions: Application of the Front-Door Formula
por: Inoue, Kosuke, et al.
Publicado: (2022)

Impact of coronavirus disease 2019 on contraception use in France
por: Roland, Noémie, et al.
Publicado: (2023)

Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines
por: Zureik, Mahmoud, et al.
Publicado: (2023)

Cyclo‐oxygenase selectivity and chemical groups of nonsteroidal anti‐inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase
por: Bakhriansyah, Mohammad, et al.
Publicado: (2019)

Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study
por: Eroglu, Talip E., et al.
Publicado: (2022)

The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany
por: Grimmsmann, Thomas, et al.
Publicado: (2020)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Non-steroidal anti-inflammatory drugs and the risk of out-of-hospital cardiac arrest: a case–control study
por: Bakhriansyah, Mohammad, et al.
Publicado: (2019)

Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention
por: Bergmeijer, Thomas O., et al.
Publicado: (2020)

Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study
por: Althunian, Turki A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t1frmro3m8k3gfbnem4t0l3s27